Shilpa Medicare Limited (NSE:SHILPAMED)
388.90
+14.20 (3.79%)
Apr 2, 2026, 3:30 PM IST
Shilpa Medicare Revenue
Shilpa Medicare had revenue of 4.10B INR in the quarter ending December 31, 2025, with 28.31% growth. This brings the company's revenue in the last twelve months to 14.33B, up 14.78% year-over-year. In the fiscal year ending March 31, 2025, Shilpa Medicare had annual revenue of 12.88B with 11.69% growth.
Revenue (ttm)
14.33B
Revenue Growth
+14.78%
P/S Ratio
5.30
Revenue / Employee
14.36M
Employees
998
Market Cap
76.03B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.88B | 1.35B | 11.69% |
| Mar 31, 2024 | 11.53B | 1.01B | 9.64% |
| Mar 31, 2023 | 10.52B | -952.56M | -8.31% |
| Mar 31, 2022 | 11.47B | 2.45B | 27.21% |
| Mar 31, 2021 | 9.02B | -66.41M | -0.73% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Alembic Pharmaceuticals | 72.67B |
| Strides Pharma Science | 47.26B |
| NATCO Pharma | 45.63B |
| Akums Drugs and Pharmaceuticals | 42.60B |
| Alivus Life Sciences | 25.12B |
| Aarti Pharmalabs | 18.01B |
| Innova Captab | 14.97B |
| Cohance Lifesciences | 10.79B |
Shilpa Medicare News
- 10 days ago - Pharma sector stocks today, March 24: Shilpa Medicare jumps 3.28%, Glenmark Pharma up 1.36%, Laurus Labs gain 1.65% - Business Upturn
- 4 weeks ago - Pharma sector stocks today, March 6: Shilpa Medicare surge 3.08%, Wockhardt jumps 2.12%, Natco Pharma up 1.84%, - Business Upturn
- 5 weeks ago - Shilpa Medicare signs strategic licensing agreement with SteinCares to commercialize biosimilar in Latin America - Business Upturn
- 7 weeks ago - Pharma sector stocks today, Feb 9: Marksans Pharma up 5%, Shilpa Medicare jumps 6%, Glenmark rises 1.83% - Business Upturn
- 2 months ago - Shilpa Medicare Ltd (BOM:530549) Q3 2026 Earnings Call Highlights: Record Revenue and Strategic ... - GuruFocus
- 2 months ago - Q3 2026 Shilpa Medicare Ltd Earnings Call Transcript - GuruFocus
- 2 months ago - Shilpa Medicare Q3 Results: Revenue jumps 28.3% YoY to Rs 409.73 crore, net profit up 40.3% - Business Upturn
- 2 months ago - Pharma sector stocks today, Feb 4: Suven Life Sciences jumps 9%, Aarti Drugs falls 6%, Shilpa Medicare up 2.80%, Mankind Pharma down 2.92% - Business Upturn